Feline Leukemia

Feline leukemia is a high-mortality disease caused by the feline leukemia virus (FeLV). FeLV produces an initial immunosuppressive infection followed by various other disease (e.g., respiratory disease, diarrhea, anemia) affecting the immunosuppressed cat. Cats that survive these initial diseases may develop some form of cancer, hence the name feline leukemia. The disease is transmitted by direct contact with infected cats or with contaminated food dishes or litter boxes. Feline leukemia vaccination is now commonplace.

 

Additional Information About Feline Leukemia

Until the development of a vaccine to protect against Feline Leukemia Virus (FeLV) infection in the mid-1980’s, the complex of diseases associated with FeLV was one of the most frequent causes of death in cats.

What is Feline Leukemia Virus (FeLV)?
Feline leukemia virus (FeLV) is one of the most important infectious viruses of cats. It was first discovered in cats with a form of leukemia, hence its name. FeLV is the cause of a variety of diseases, not just leukemia. Like all viruses, FeLV is a minute micro-organism consisting of nucleic acid and a few proteins and glycoproteins in a simple structure. Viruses can only replicate themselves inside living cells. FeLV is specific to members of the cat family and does not pose a risk to other animals or people.

How common is FeLV?
FeLV infection is found worldwide. In general, around 1-2% of the cat population is persistently infected with this virus, and many more are exposed. The proportion of cats infected differs according to the geographical location, environment and the life-style of the cat. Infection is more common in colonies of cats where there is close contact between individuals.

What disease does the virus cause?
FeLV invades and replicates in various cells of the cat’s immune system and blood-forming tissues, as well as other cells. To replicate, the nucleic acid (genetic code) of FeLV inserts itself into the nucleic acid of the cells it has invaded. The result can be death of the cell or a change in its genetic code. Such a change can make the cell potentially cancerous and lead to neoplastic disease (cancer). The cancerous change may not occur for months or years after infection.

Cancers can occur in a variety of tissues, organs and body sites, depending on the type and location of cells that have been infected with FeLV. Such cancers can involve any type of the circulating white blood cells (leukemia) or other cells of the reticulo-endothelial system. The most common tumor associated with FeLV is that of lymphoid cells known as lymphoma or lymphosarcoma. These tumors may occur at single or multiple sites in the body.

Although the development of cancer is one outcome of FeLV infection, other diseases more commonly develop. In many cats, FeLV infection results in a moderate to severe suppression of the immune system. This means that the infected cat is less able to defend itself against a wide range of infections that would not normally cause a problem in healthy cats. A variety of clinical signs develop in these cats, and there is a progressive deterioration in their health over time.

Another common occurrence in FeLV-infected cats is the development of a profound and life-threatening anemia. Other diseases, including abortion, severe enteritis (causing diarrhea), neurological (nervous) signs, and ocular (eye) disease are commonly associated with FeLV infection.

FeLV is usually fatal. Studies have shown that 80-90% of FeLV-infected cats will die within three to four years of initial diagnosis.

How is FeLV transmitted?
Direct contact between cats is the most frequent method of FeLV infection. The virus is fragile and cannot survive longer than a few hours in the environment outside of the cat. A cat with FeLV sheds a large quantity of the virus in its saliva as well as in other bodily fluids such as urine and feces. However, FeLV is not a highly contagious virus, and transmission generally requires a prolonged period of close contact between infected and susceptible cats. Close contact activities include mating, mutual grooming, and sharing of litter trays and food bowls. Cat bites by an infected cat can readily transmit infection.

Another potential source of infection is when a pregnant cat infected with FeLV gives birth. In this situation, all the kittens will likely be born with FeLV virus. Fortunately, it is more likely that a queen infected with FeLV becomes infertile or there is pre-natal death of the kittens with abortion or resorption of the fetuses.

What happens when a cat is exposed to FeLV?
Not all cats exposed to FeLV will develop persistent infections. Many of the cats that are infected are able to mount an immune response to the virus. This immunity is successful in eliminating the virus in approximately 30% of the cats exposed to FeLV. However, there will have been a period of some weeks when the virus has been replicating in those cats before they cleared the infection. During the period when FeLV was replicating inside those cats’ cells, there may have been cell changes that could lead to disease later in life.

Approximately 70% of cats are unable to mount an immune response to eliminate the virus. Following infection, these cats become persistently and permanently infected with the virus and are at the highest risk of developing FeLV-related disease. It is the permanently infected cats that are primarily responsible for the transmission of FeLV to other cats. It can be many months or even years between the initial virus infection and the onset of related clinical disease problems.

How can FeLV infection be diagnosed?
Diagnosis of FeLV infection is relatively simple. A rapid blood test can be performed which is able to detect viral proteins of FeLV in the blood of an infected cat. This test is very accurate and reliable; although false results may rarely occur. In addition, some cats with only a transient FeLV infection will be positive on the blood test. A second test performed eight to twelve weeks after the first test may be required to confirm persistent infection. In some situations it may be necessary to confirm infection through further blood testing at a specialized laboratory where more sophisticated tests are available.

Diagnosis of FeLV disease is more difficult because of the variety of signs and symptoms. It is common to have a complicated situation in which other diseases or conditions co-exist with, and are promoted by, the FeLV infection.

Is there any treatment for FeLV infection or disease?
There is currently no specific treatment for FeLV-infected cats. There is no treatment to eliminate the virus from the body. Most FeLV-infected cats will eventually die or be euthanized because of diseases related to their infection. However, many cats showing FeLV-related disease will improve with symptomatic treatment, at least for a period of time. For example, if FeLV is causing immunosuppression and the patient develops secondary infections, the secondary infections may be treatable, leading to clinical improvement.

How can infection be prevented?
Vaccines are available to protect cats against FeLV infection. Their use is highly recommended for any cat that goes outside at any time and therefore could have contact with FeLV- infected cats. As with other vaccines, an initial course of two injections is required, and regular boosters are necessary to maintain immunity. Your veterinarian will discuss the most appropriate options for your cat with you. All cats should be tested for FeLV prior to vaccination.

Although vaccination is very helpful in preventing infection with FeLV and thus controlling FeLV-related disease, no vaccine is 100% protective. Where possible do not allow your cat, particularly if a kitten, to come into close contact with known FeLV-infected cats or cats without a known history of proper vaccinations.

In larger colonies of cats, it is possible to control FeLV infection through a combination of routine FeLV testing, quarantine and vaccination programs. Fortunately, vaccinating a cat does not interfere with subsequent blood testing for FeLV.